$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

$ssy Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-K Financial Statement

#000119312516726649 Filed on September 30, 2016

Income Statement

Concept	2015 Q2	2015 Q1	2014 Q4
Revenue	$18.47M	$19.29M	$25.11M
YoY Change	-14.47%	-36.21%	-3.84%
Cost Of Revenue	$4.790M	$1.382M	$1.162M
YoY Change	12.18%	7.21%	-13.93%
Gross Profit	$100.0K	$17.91M	$23.95M
YoY Change	-111.36%	-38.15%	-3.29%
Gross Profit Margin	0.54%	92.83%	95.37%
Selling, General & Admin	$220.0K	$14.22M	$14.10M
YoY Change	-115.71%	0.64%	-2.96%
% of Gross Profit	220.0%	79.41%	58.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.680M	$602.0K	$580.0K
YoY Change	-26.78%	-22.12%	-23.98%
% of Gross Profit	2680.0%	3.36%	2.42%
Operating Expenses	-$70.00K	$17.46M	$16.64M
YoY Change	-97.12%	-2.18%	-2.69%
Operating Profit	$170.0K	-$285.0K	$2.022M
YoY Change	-89.03%	-38.71%	594.85%
Interest Expense	-$180.0K	$213.0K	$234.0K
YoY Change	-21.74%	-8.97%	-1.68%
% of Operating Profit	-105.88%		11.57%
Other Income/Expense, Net	-$310.0K	$0.00	$1.970M
YoY Change	-70.19%	-100.0%	51.77%
Pretax Income	$0.00	-$485.0K	$1.788M
YoY Change	-100.0%	-28.78%	3273.58%
Income Tax	$80.00K	-$169.0K	$799.0K
% Of Pretax Income			44.69%
Net Earnings	$92.00K	-$411.0K	$977.0K
YoY Change	-93.19%	-57.37%	330.4%
Net Earnings / Revenue	0.5%	-2.13%	3.89%
Basic Earnings Per Share	$0.01	-$0.04	$0.10
Diluted Earnings Per Share	$0.01	-$0.04	$0.10
COMMON SHARES
Basic Shares Outstanding	9.443M shares	9.443M shares	9.443M shares
Diluted Shares Outstanding	9.490M shares	9.443M shares	9.497M shares

Balance Sheet

Concept	2015 Q2	2015 Q1	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.000M	$4.900M	$4.000M
YoY Change	66.67%	28.95%	-13.04%
Cash & Equivalents	$5.974M	$4.885M	$3.971M
Short-Term Investments
Other Short-Term Assets	$8.300M	$6.100M	$8.500M
YoY Change	-2.35%	-29.89%	-16.67%
Inventory	$3.148M	$3.936M	$4.047M
Prepaid Expenses
Receivables	$7.700M	$1.525M	$2.672M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.09M	$24.93M	$27.66M
YoY Change	-2.65%	-11.12%	-7.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.24M	$22.54M	$22.82M
YoY Change	-38.94%	-23.0%	-23.33%
Goodwill	$461.0K	$461.0K	$461.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles	$2.837M	$2.873M	$2.908M
YoY Change	-4.77%	-6.33%	-6.28%
Long-Term Investments
YoY Change
Other Assets	$1.520M	$1.522M	$1.550M
YoY Change	48.29%	2.98%	3.68%
Total Long-Term Assets	$32.04M	$32.49M	$32.18M
YoY Change	-15.85%	-15.77%	-16.68%
TOTAL ASSETS
Total Short-Term Assets	$25.09M	$24.93M	$27.66M
Total Long-Term Assets	$32.04M	$32.49M	$32.18M
Total Assets	$57.13M	$57.42M	$59.84M
YoY Change	-10.52%	-13.81%	-12.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.688M	$4.429M	$5.433M
YoY Change	-40.66%	-14.4%	-6.6%
Accrued Expenses	$0.00	$5.400M	$6.200M
YoY Change	-100.0%	-8.47%	6.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$816.0K	$840.0K	$866.0K
YoY Change	45.45%	-90.87%	0.12%
Total Short-Term Liabilities	$10.76M	$10.70M	$12.61M
YoY Change	-34.79%	-55.31%	-21.81%
LONG-TERM LIABILITIES
Long-Term Debt	$11.23M	$11.47M	$11.58M
YoY Change	-6.02%	35.74%	-31.63%
Other Long-Term Liabilities	$681.0K	$755.0K	$786.0K
YoY Change	-15.61%	-10.86%	-1.63%
Total Long-Term Liabilities	$12.80M	$13.22M	$13.33M
YoY Change	-8.69%	22.39%	-31.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.76M	$10.70M	$12.61M
Total Long-Term Liabilities	$12.80M	$13.22M	$13.33M
Total Liabilities	$23.57M	$23.92M	$25.94M
YoY Change	-22.8%	-31.15%	-27.31%
SHAREHOLDERS EQUITY
Retained Earnings	$15.73M	$15.64M	$16.05M
YoY Change	1.58%	10.63%	6.29%
Common Stock	$18.20M	$18.20M	$18.19M
YoY Change	0.2%	285.43%	285.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.60M	$33.50M	$33.90M
YoY Change
Total Liabilities & Shareholders Equity	$57.13M	$57.42M	$59.84M
YoY Change	-10.52%	-13.81%	-12.68%

Cashflow Statement

Concept	2015 Q2	2015 Q1	2014 Q4
OPERATING ACTIVITIES
Net Income	$92.00K	-$411.0K	$977.0K
YoY Change	-93.19%	-57.37%	330.4%
Depreciation, Depletion And Amortization	$2.680M	$602.0K	$580.0K
YoY Change	-26.78%	-22.12%	-23.98%
Cash From Operating Activities	$1.650M	$1.340M	$890.0K
YoY Change	189.47%	-682.61%	-23.28%
INVESTING ACTIVITIES
Capital Expenditures	-$300.0K	$258.0K	$319.0K
YoY Change	-41.18%	-23.21%	-21.43%
Acquisitions
YoY Change
Other Investing Activities	$30.00K	$0.00	$6.090M
YoY Change		-100.0%	-7712.5%
Cash From Investing Activities	-$270.0K	-$260.0K	$5.770M
YoY Change	-47.06%	-27.78%	-1302.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-280.0K	-170.0K	-4.770M
YoY Change	-6.67%	13.33%	1438.71%
NET CHANGE
Cash From Operating Activities	1.650M	1.340M	890.0K
Cash From Investing Activities	-270.0K	-260.0K	5.770M
Cash From Financing Activities	-280.0K	-170.0K	-4.770M
Net Change In Cash	1.100M	910.0K	1.890M
YoY Change	-558.33%	-222.97%	410.81%
FREE CASH FLOW
Cash From Operating Activities	$1.650M	$1.340M	$890.0K
Capital Expenditures	-$300.0K	$258.0K	$319.0K
Free Cash Flow	$1.950M	$1.082M	$571.0K
YoY Change	80.56%	-291.17%	-24.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	ssy	Minimum Outstanding Stock Percentage Required To Trigger Poison Pill MinimumOutstandingStockPercentageRequiredToTriggerPoisonPill	0.20	pure
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9443408	shares
CY2015Q4	dei	Entity Public Float EntityPublicFloat	4837749
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.62
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400499	shares
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2497000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-406000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-406000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.92
CY2013Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33743000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	617499	shares
CY2014Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1366000
CY2014Q2	us-gaap	Assets Assets	63847000
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4432000
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3587000
CY2014Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	816000
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-334000
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-334000
CY2014Q2	us-gaap	Former Gain Contingency Recognized In Current Period FormerGainContingencyRecognizedInCurrentPeriod	3087000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.97
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.71
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	448998	shares
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33318000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	548999	shares
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3475000
CY2015Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1476000
CY2015Q2	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-628000
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	64000
CY2015Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	16062000
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20743000
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9444000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9444000	shares
CY2015Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-628000
CY2015Q2	us-gaap	Assets Assets	57128000
CY2015Q2	us-gaap	Assets Current AssetsCurrent	25092000
CY2015Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2564000
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2015Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1365000
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	13481000
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	238000
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2770000
CY2015Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	137000
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5974000
CY2015Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4885000
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	4722000
CY2015Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	848000
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2688000
CY2015Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6852000
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	281000
CY2015Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1967000
CY2015Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	8090000
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-374000
CY2015Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2789000
CY2015Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9416000
CY2015Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4096000
CY2015Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	10449000
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-374000
CY2015Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2627000
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	0
CY2015Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	600000
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2015Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11229000
CY2015Q2	us-gaap	Long Term Debt LongTermDebt	12045000
CY2015Q2	us-gaap	Former Gain Contingency Recognized In Current Period FormerGainContingencyRecognizedInCurrentPeriod	753000
CY2015Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	816000
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12804000
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2837000
CY2015Q2	us-gaap	Inventory Net InventoryNet	3148000
CY2015Q2	us-gaap	Land Land	1155000
CY2015Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1378000
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57128000
CY2015Q2	us-gaap	Goodwill Goodwill	461000
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	681000
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10764000
CY2015Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	17793000
CY2015Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2343000
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1520000
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14243000
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34986000
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.73
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.46
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	470142	shares
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33560000
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15731000
CY2015Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	1126000
CY2015Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2409000
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	67000
CY2015Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17769000
CY2015Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	7679000
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	590142	shares
CY2015Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	1365000
CY2015Q2	ssy	Prepaid Accrued Benefit Cost PrepaidAccruedBenefitCost	28000
CY2015Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	894000
CY2015Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	28000
CY2015Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	556000
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2872000
CY2016Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1583000
CY2016Q2	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-757000
CY2016Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2000
CY2016Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	14286000
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20920000
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9444000	shares
CY2016Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	62000
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9444000	shares
CY2016Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-757000
CY2016Q2	us-gaap	Assets Assets	44841000
CY2016Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	65000
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	142000
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	142000
CY2016Q2	us-gaap	Assets Current AssetsCurrent	17901000
CY2016Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10652000
CY2016Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	68000
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2016Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	714000
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	13539000
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	282000
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	991000
CY2016Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	94000
CY2016Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	32000
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3261000
CY2016Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1698000
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	125000
CY2016Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	62000
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	4722000
CY2016Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	826000
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3391000
CY2016Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2322000
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	93000
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	51000
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	136000
CY2016Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	624000
CY2016Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	7633000
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-420000
CY2016Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2461000
CY2016Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12974000
CY2016Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8529000
CY2016Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	7157000
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-420000
CY2016Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2147000
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1883000
CY2016Q2	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	676000
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1168000
CY2016Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1720000
CY2016Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	13700000
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2016Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3176000
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	31000
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	155000
CY2016Q2	us-gaap	Long Term Debt LongTermDebt	11188000
CY2016Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	49000
CY2016Q2	us-gaap	Former Gain Contingency Recognized In Current Period FormerGainContingencyRecognizedInCurrentPeriod	-100000
CY2016Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	8012000
CY2016Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	51000
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4762000
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	530642	shares
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19489000
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1648000
CY2016Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	0
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	472000
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2695000
CY2016Q2	us-gaap	Inventory Net InventoryNet	2612000
CY2016Q2	us-gaap	Land Land	1155000
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1685000
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44841000
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	695000
CY2016Q2	us-gaap	Goodwill Goodwill	461000
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	425000
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20590000
CY2016Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	13946000
CY2016Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	46000
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	196000
CY2016Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1310000
CY2016Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2745000
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1459000
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	142000
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	11188000
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2016Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	8012000
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	314000
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12994000
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33914000
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.16
CY2016Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	25000
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.07
CY2016Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2777000
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2016Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	18473000
CY2016Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	6166000
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	635642	shares
CY2016Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Five LongTermDebtContractualCommitmentsForInterestInYearFive	96000
CY2016Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year After Five Year LongTermDebtContractualCommitmentsForInterestInYearAfterFiveYear	1015000
CY2016Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	1155000
CY2016Q2	ssy	Plans Assets Invested In Equity Investments PlansAssetsInvestedInEquityInvestments	0.27	pure
CY2016Q2	ssy	Plan Expected To Pay In Pension Benefits Through Three Years PlanExpectedToPayInPensionBenefitsThroughThreeYears	431000
CY2016Q2	ssy	Prepaid Accrued Benefit Cost PrepaidAccruedBenefitCost	81000
CY2016Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Three LongTermDebtContractualCommitmentsForInterestInYearThree	101000
CY2016Q2	ssy	Long Term Debt Contractual Commitments For Interest In Next Twelve Months LongTermDebtContractualCommitmentsForInterestInNextTwelveMonths	685000
CY2016Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	1161000
CY2016Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Two LongTermDebtContractualCommitmentsForInterestInYearTwo	136000
CY2016Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Four LongTermDebtContractualCommitmentsForInterestInYearFour	99000
CY2016Q2	ssy	Plans Assets Invested In Cash And Short Term Investments PlansAssetsInvestedInCashAndShortTermInvestments	0.57	pure
CY2016Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	81000
CY2016Q2	ssy	Long Term Debt Contractual Commitments LongTermDebtContractualCommitments	2132000
CY2016Q2	ssy	Plans Assets Invested In Fixed Income Investments PlansAssetsInvestedInFixedIncomeInvestments	0.16	pure
CY2016Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	-11000
CY2015Q1	us-gaap	Insurance Recoveries InsuranceRecoveries	1000000
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.13
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	260000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	43000	shares
CY2013	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.22
CY2014	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	1307000
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	95000
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0000	pure
CY2014	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48000
CY2014	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	-3000
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1090000
CY2014	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	928000
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	48000
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2014	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	5632000
CY2014	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0	pure
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2322000
CY2014	us-gaap	Depreciation Depreciation	2180000
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3662000
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-473000
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	142000
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	22110000
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-64000
CY2014	us-gaap	Cost Of Services CostOfServices	3288000
CY2014	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-61000
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	446000
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	73769000
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1842000
CY2014	us-gaap	Interest Paid InterestPaid	1128000
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	13000
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	877000
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-61000
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	20000
CY2014	us-gaap	Labor And Related Expense LaborAndRelatedExpense	32771000
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	72000
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	460000
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-545000
CY2014	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	9142000
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	255000
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1358000
CY2014	us-gaap	Interest Expense InterestExpense	944000
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	72000
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	16000
CY2014	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	3795000
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3892000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-919000
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2014	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1393000
CY2014	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-41000
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	249000
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	1042000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1883000
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-41000
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-912000
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1881000
CY2014	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-484000
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.05
CY2014	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	32000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	57000
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	541000
CY2014	us-gaap	Insurance Recoveries InsuranceRecoveries	0
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1483000
CY2014	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.05
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	160000
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9456000	shares
CY2014	us-gaap	Supplies Expense SuppliesExpense	4236000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.71
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.71
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	13000	shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.15
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.93	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	89500	shares
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	48000
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	795000
CY2014	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	3342000
CY2014	ssy	Financial And Healthcare Services Revenue FinancialAndHealthcareServicesRevenue	77564000
CY2014	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1484000
CY2014	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	44000
CY2014	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	239000
CY2014	ssy	Incentive Payments Received Repaid IncentivePaymentsReceivedRepaid	1780000
CY2014	ssy	Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss	2274000
CY2014	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	1135000
CY2014	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	0.71
CY2014	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	803000
CY2014	ssy	Repayments Of Long Term Debt Discontinued Operations RepaymentsOfLongTermDebtDiscontinuedOperations	124000
CY2014	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	72000
CY2014	ssy	Health Care Organization Significant Change In Estimates HealthCareOrganizationSignificantChangeInEstimates	624000
CY2015	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	732000
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	38000
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0000	pure
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37000
CY2015	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	-173000
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2387000
CY2015	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-664000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	37000
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2015	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	2266000
CY2015	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	112000
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1837000
CY2015	us-gaap	Depreciation Depreciation	1695000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2938000
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.02
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2681000
CY2015	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	60000
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	205000
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	142000
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	21042000
CY2015	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-218000
CY2015	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	67000
CY2015	us-gaap	Cost Of Services CostOfServices	3616000
CY2015	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	-13000
CY2015	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2015	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-242000
CY2015	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	117000
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	7452000
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	855000
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	73746000
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-9000
CY2015	us-gaap	Interest Paid InterestPaid	914000
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	81000
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	818000
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-242000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	469000
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	33620000
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	56000
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-40000
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	215000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	245000
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6893000
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	363000
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-444000
CY2015	us-gaap	Interest Expense InterestExpense	861000
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-40000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	12000
CY2015	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	3678000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5362000
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.02
CY2015	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	6090000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	279000
CY2015	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	21000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	20000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	2220000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4811000
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	21000
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1890000
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	57000
CY2015	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1235000
CY2015	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	487000
CY2015	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	25000
CY2015	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	78000
CY2015	ssy	Incentive Payments Received Repaid IncentivePaymentsReceivedRepaid	21000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	37000
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.05
CY2015	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	116000
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1380000
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	695000
CY2015	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-1660000
CY2015	ssy	Financial And Healthcare Services Revenue FinancialAndHealthcareServicesRevenue	77424000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	893000
CY2015	us-gaap	Insurance Recoveries InsuranceRecoveries	1000000
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1235000
CY2015	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2015	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.05
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	34000
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9496000	shares
CY2015	us-gaap	Supplies Expense SuppliesExpense	4366000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.49
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.49
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	53000	shares
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.50
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	175000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.84	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	90000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0203	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	48857	shares
CY2015	ssy	Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss	29000
CY2015	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	0
CY2015	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.49
CY2015	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	557000
CY2015	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	600000
CY2015	ssy	Repayments Of Long Term Debt Discontinued Operations RepaymentsOfLongTermDebtDiscontinuedOperations	4842000
CY2015	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	-40000
CY2015	ssy	Health Care Organization Significant Change In Estimates HealthCareOrganizationSignificantChangeInEstimates	-540000
CY2016	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-93000
CY2016	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2016	dei	Entity Registrant Name EntityRegistrantName	SUNLINK HEALTH SYSTEMS INC
CY2016	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	1801000
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2000
CY2016	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0000	pure
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	636000	shares
CY2016	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0000096793
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	58000
CY2016	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2713000
CY2016	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	729000
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	58000
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.49
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> <b><i>Concentrations of Credit Risk</i></b>—SunLink’s Healthcare Facilities segment subsidiaries grant unsecured credit to their patients, most of who reside in the service area of the subsidiaries’ facilities and are insured under third-party agreements. Medicare and Medicaid patient accounts represent SunLink’s only significant concentrations of credit risk. For SunLink’s Healthcare Facilities Segment, Medicare net revenues were approximately 37%, 39%, and 40% of net revenues for the years ended June 30, 2016, 2015 and 2014, respectively. For SunLink’s Healthcare Facilities Segment, Medicaid was approximately 37%, 30%, and 29% of net revenues for the years ended June 30, 2016, 2015 and 2014, respectively. For SunLink’s Healthcare Facilities Segment, Medicare receivables were approximately 51% and 45% of receivables—net at June 30, 2016 and 2015, respectively, while Medicaid receivables were approximately 22% and 15% of receivables—net at June 30, 2016 and 2015, respectively.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> SunLink’s Specialty Pharmacy segment subsidiary grants unsecured credit to individual customers and institutional customers. Individual customers primarily are insured under third-party agreements, including Medicare and Medicaid, while the institutional customers are grant credit according to their determined credit risk. Medicare receivables were approximately 13% and 18% of the Specialty Pharmacy’s receivables at June 30, 2016 and 2015, respectively, while Medicaid receivables were approximately 10% and 12% of the segments receivable at June 30, 2016 and 2015, respectively. Approximately 77% and 70% of the Specialty Pharmacy’s net receivables at June 30, 2016 and 2015, respectively, were private insurance and institutional customers’ receivables. Net revenues for the Specialty Pharmacy segment for the fiscal year ended June 30, 2016 and 2015 were approximately 16% and 8% Medicare, respectively, and approximately 10% and 14% Medicaid, respectively.</p> </div>
CY2016	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	128000
CY2016	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0	pure
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1878000
CY2016	us-gaap	Depreciation Depreciation	1736000
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2436000
CY2016	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	65000
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.49
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14129000
CY2016	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	142000
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	20404000
CY2016	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-2169000
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	us-gaap	Defined Benefit Plan Benefits Paid DefinedBenefitPlanBenefitsPaid	127000
CY2016	us-gaap	Defined Benefit Plans Estimated Future Employer Contributions In Next Fiscal Year DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear	140000
CY2016	us-gaap	Cost Of Services CostOfServices	3248000
CY2016	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	-23000
CY2016	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2016	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-2169000
CY2016	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	169000
CY2016	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3712000
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4556000
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	63433000
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-62000
CY2016	us-gaap	Interest Paid InterestPaid	768000
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	94000
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	791000
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2169000
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2501000
CY2016	us-gaap	Labor And Related Expense LaborAndRelatedExpense	30783000
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-46000
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7350000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-14083000
CY2016	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	8031000
CY2016	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	Depreciation is recognized over the estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	630000
CY2016	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1513000
CY2016	us-gaap	Interest Expense InterestExpense	843000
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-46000
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.23
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	20000
CY2016	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	1438000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-426000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-857000
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.23
CY2016	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	309000
CY2016	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	10000
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-536000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-6523000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1430000
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	15000
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	374000
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	78000
CY2016	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-11914000
CY2016	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.26
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	21000
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1347000
CY2016	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	858000
CY2016	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.26
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0
CY2016	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	-405000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7356000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4558000
CY2016	us-gaap	Nature Of Operations NatureOfOperations	<div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><b>1.</b></td> <td valign="top" align="left"><b>BUSINESS OPERATIONS</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> SunLink Health Systems, Inc., through subsidiaries (“SunLink”, “we”, “our”, “ours”, “us” or the “Company”), owns businesses which are providers of healthcare services in certain markets in the United States. SunLink’s business is composed of the ownership of two business segments:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">The Healthcare Facilities Segments, which is composed of:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">A subsidiary which owns and operates an 84-licensed-bed, acute care hospital, which includes an 18-bed GPU, and a 66-bed nursing home.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">A subsidiary which owns and operates a 100-bed nursing home. This subsidiary also owns a hospital facility and leases the emergency department to outside third party.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Two separate subsidiaries which own medical buildings, which are leased to unaffiliated healthcare providers.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">A subsidiary which owns a closed hospital building and a medical office building which it currently rents an office to an unaffiliated healthcare provider.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">The Specialty Pharmacy Segment, which is composed of four operational areas:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Retail pharmacy products and services, all of which are conducted in rural markets;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Institutional pharmacy services;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Specialty pharmacy services; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">  </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%"> </td> <td valign="top" width="2%" align="left">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left">Durable medical equipment.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the specialty pharmacy operations since 2008. Our Specialty Pharmacy Segment currently is operated through Carmichael’s Cashway Pharmacy, Inc. (“Carmichael”), a subsidiary of our SunLink ScriptsRx, LLC subsidiary, and is composed of a specialty pharmacy business acquired in April 2008 with four service lines.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> On August 19, 2016, a subsidiary of the Company sold substantially all assets and certain liabilities of its Chestatee Regional Hospital in Dahlonega, GA, for approximately $15,000 subject to adjustment for the book value of certain assets and liabilities at the sale date. In addition, the Company has entered into an agreement to lease the emergency department and certain ancillary space located in its former hospital, North Georgia Medical Center, which is now closed, to a regional healthcare system. The lease transaction is subject to a number of conditions precedent including regulatory approval and negotiation of definitive leases. The Company continues to operate its 100-bed skilled nursing facility which is located adjacent to the closed hospital. The Company believes its specialty pharmacy business continues to under-perform, and the Company has engaged advisors to assist it in evaluating the sale of its specialty pharmacy business and one medical office building. The Company’s possible use of net proceeds from the Dahlonega sale and possible future transactions may include, among other things, a prepayment of long-term debt, a return of capital to shareholders via a repurchase of shares or a dividend, and other general corporate purposes. However, there can be no assurance any further sale or lease transaction will be authorized by the Board of Directors or completed or, if completed, that there will be sufficient proceeds to return capital to shareholders or for future development or other general corporate purposes.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Throughout these notes to the consolidated financial statements, SunLink Health Systems, Inc., and its consolidated subsidiaries are referred to on a collective basis as “SunLink”, “we”, “our”, “ours”, “us” or the “Company.” This drafting style is not meant to indicate that the publicly traded Company or any particular subsidiary of the Company owns or operates any asset, business or property. The Trace Hospital, pharmacy operations and businesses described in this filing are owned and operated by distinct and indirect subsidiaries of SunLink Health System, Inc.</p> </div>
CY2016	us-gaap	Insurance Recoveries InsuranceRecoveries	0
CY2016	us-gaap	Malpractice Insurance Description MalpracticeInsuranceDescription	Claim made under its insurance policy covering, among other things, employee theft relating to misappropriation of funds by two now former employees over an eight year period beginning in 2006.
CY2016	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> <b><i>Management Estimates</i></b>—The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates made by management involve reserves for adjustments to net patient service revenues, evaluation of the recoverability of assets, including accounts receivable and intangible assets, and the assessment of litigation and contingencies, including income taxes and related tax asset valuation allowances, all as discussed in more detail in the remainder of these notes to the consolidated financial statements. Actual results could differ materially from these estimates.</p> </div>
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2016	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	Estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis
CY2016	us-gaap	Supplies Expense SuppliesExpense	3326000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.79
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.79
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.05
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2016	dei	Trading Symbol TradingSymbol	SSY
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.80	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	75000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0163	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	29500	shares
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	58000
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	857000
CY2016	ssy	Age Of Participants To Take Monthly Pension Benefits One AgeOfParticipantsToTakeMonthlyPensionBenefitsOne	P65Y
CY2016	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-3009000
CY2016	ssy	Financial And Healthcare Services Revenue FinancialAndHealthcareServicesRevenue	64871000
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
CY2016	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1347000
CY2016	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	28000
CY2016	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	104000
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2016	ssy	Incentive Payments Received Repaid IncentivePaymentsReceivedRepaid	-7000
CY2016	ssy	Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss	-7000
CY2016	ssy	Increase Decrease In Deferred Gain IncreaseDecreaseInDeferredGain	0
CY2016	ssy	Maximum Period Of Accounts Receivable Written Off MaximumPeriodOfAccountsReceivableWrittenOff	P120D
CY2016	ssy	Net Operating Loss Carryforward Expiration Year NetOperatingLossCarryforwardExpirationYear	2024
CY2016	ssy	Defined Contribution Plan Employer Matching Contribution DefinedContributionPlanEmployerMatchingContribution	120000
CY2016	ssy	Expected Return On Investment ExpectedReturnOnInvestment	0.04	pure
CY2016	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.79
CY2016	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	4530000
CY2016	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	676000
CY2016	ssy	Repayments Of Long Term Debt Discontinued Operations RepaymentsOfLongTermDebtDiscontinuedOperations	0
CY2016	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	-46000
CY2016	ssy	Health Care Organization Significant Change In Estimates HealthCareOrganizationSignificantChangeInEstimates	786000
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	19288000
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-411000
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	14060000
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-1234000
CY2016Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-823000
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	92000
CY2015Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-7000
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.00
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9490000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-940000
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	16205000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-1835000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1392000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.15
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	18474000
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	17480000
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-413000
CY2014Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-199000
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.02
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.02
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2014Q4	us-gaap	Sales Revenue Net SalesRevenueNet	18504000
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	977000
CY2014Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1633000
CY2014Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.17
CY2014Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.17
CY2014Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9497000	shares
CY2014Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	16583000
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-1668000
CY2015Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1133000
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.12
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.99
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.99
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	16585000
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-9346000
CY2015Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-8566000
CY2015Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.91
CY2015Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.91
CY2015Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2015Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares

Files In Submission

Name	View Source	Status
0001193125-16-726649-index-headers.html	Edgar Link	pending
0001193125-16-726649-index.html	Edgar Link	pending
0001193125-16-726649.txt	Edgar Link	pending
0001193125-16-726649-xbrl.zip	Edgar Link	pending
d213211d10k.htm	Edgar Link	pending
d213211dex211.htm	Edgar Link	pending
d213211dex231.htm	Edgar Link	pending
d213211dex311.htm	Edgar Link	pending
d213211dex312.htm	Edgar Link	pending
d213211dex321.htm	Edgar Link	pending
d213211dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g213211g73i63.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssy-20160630.xml	Edgar Link	completed
ssy-20160630.xsd	Edgar Link	pending
ssy-20160630_cal.xml	Edgar Link	unprocessable
ssy-20160630_def.xml	Edgar Link	unprocessable
ssy-20160630_lab.xml	Edgar Link	unprocessable
ssy-20160630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

2015 Q2 Form 10-K Financial Statement

#000119312516726649 Filed on September 30, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY SUNLINK HEALTH SYSTEMS INC Stock $ssy

2015 Q2 Form 10-K Financial Statement

#000119312516726649 Filed on September 30, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy